SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001104659-22-099008
Filing Date
2022-09-12
Accepted
2022-09-09 21:34:40
Documents
5

Document Format Files

Seq Description Document Type Size
1 F-1/A tm2222207-7_f1a.htm F-1/A 143235
2 EXHIBIT 4.2 tm2222207d8_ex4-2.htm EX-4.2 104450
3 EXHIBIT 4.3 tm2222207d8_ex4-3.htm EX-4.3 99213
4 EXHIBIT 4.4 tm2222207d8_ex4-4.htm EX-4.4 81248
5 EXHIBIT 10.14 tm2222207d8_ex10-14.htm EX-10.14 82195
  Complete submission text file 0001104659-22-099008.txt   511310
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-267328 | Film No.: 221237241
SIC: 2834 Pharmaceutical Preparations